These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 18787882)

  • 1. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
    Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
    Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
    O'Sullivan SS; Evans AH; Lees AJ
    CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.
    O'Sullivan SS; Wu K; Politis M; Lawrence AD; Evans AH; Bose SK; Djamshidian A; Lees AJ; Piccini P
    Brain; 2011 Apr; 134(Pt 4):969-78. PubMed ID: 21349901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.
    Antonini A; Cilia R
    Drug Saf; 2009; 32(6):475-88. PubMed ID: 19459715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
    Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
    Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
    Lopez AM; Weintraub D; Claassen DO
    Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management.
    Wu K; Politis M; Piccini P
    Postgrad Med J; 2009 Nov; 85(1009):590-6. PubMed ID: 19892894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control and related disorders in Parkinson's disease.
    Weintraub D; Nirenberg MJ
    Neurodegener Dis; 2013; 11(2):63-71. PubMed ID: 23038208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
    Fenu S; Wardas J; Morelli M
    Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework.
    Okai D; Samuel M; Askey-Jones S; David AS; Brown RG
    Eur J Neurol; 2011 Dec; 18(12):1379-83. PubMed ID: 21615625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Repetitive impulse-associated behavioral disorders in Parkinson's disease].
    Katzenschlager R; Goerlich KS; van Eimeren T
    Nervenarzt; 2012 Dec; 83(12):1582-9. PubMed ID: 22878676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addictive behaviors and Parkinson's disease.
    Witjas T; Eusebio A; Fluchère F; Azulay JP
    Rev Neurol (Paris); 2012; 168(8-9):624-33. PubMed ID: 22921247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.